logo
Gilead Sciences: Using Lessons From the HIV Epidemic To Help Reduce Stigma Around Lung Cancer

Gilead Sciences: Using Lessons From the HIV Epidemic To Help Reduce Stigma Around Lung Cancer

HIV infection and lung cancer have little in common from a disease perspective, but the stigma that surrounds both can negatively impact patients and their treatment. Now lessons learned from the HIV epidemic are helping people living with lung cancer and their loved ones.
During the first years of the HIV epidemic, some of the initial stigmatizing beliefs were that the virus only impacted men who have sex with men and that it was possible to contract it by sharing utensils or being in close confines with a person living with HIV. This helped contribute to acts of discrimination and an atmosphere of blame, and in some cases prevented people from getting diagnosed or seeking care.
People diagnosed with lung cancer face similar stigma challenges because of the known link to tobacco use – despite the National Cancer Institute's estimate that 10-20% of people with lung cancer in the United States are non-smokers. As with HIV, the blame and stigma surrounding this disease can decrease the likelihood that someone experiencing symptoms will seek care.
'Stigma isn't just a social issue; it's a public health crisis.' says Marcus Wilson, Gilead Senior Director, U.S. Public Affairs, HIV Advocacy. 'It determines the quality of care that people receive; whether they feel safe seeking care and, ultimately, their health outcomes.'
Gilead recently partnered with GRYT Health to host a New Lens on Lung Cancer workshop where people living with lung cancer and their loved ones shared their experience with stigma.
Rhonda Meckstroth's husband, Jeff, who had no history of tobacco use, was diagnosed with lung cancer in 2015. 'The first question was always, 'Is he a smoker?'' she says. 'We innately felt shame and guilt and would tell people he had been diagnosed with cancer, but we didn't want to say lung cancer.'
'People project their ideas of why you have lung cancer,' says Aurora Lucas, who was diagnosed at 28 years old. 'Within seconds they come up with absurd ideas.' She notes that some people speculated that it could be because she worked in a nail salon. Others incorrectly assumed it might be due to the building materials used in her childhood home in the Philippines.
As in the early days of the HIV epidemic, the lung cancer community quickly realized how important it is to advocate for themselves, both in and out of the clinic.
In Jeff's case, his care was in a rural health care system where doctors weren't always familiar with the latest research or the clinical trials available for lung cancer — or the fact that there are other risk factors besides tobacco use.
'Because Jeff didn't fit the criteria for lung cancer, his diagnosis was delayed for about six months,' says Rhonda. 'I quickly learned that instead of being angry when people asked me if Jeff had a history of tobacco use, I use it as a platform for education, and to put blame where it needs to be, which is on the tobacco industry.'
'We have so much to learn from the HIV community,' says Jeff Stibelman, who was diagnosed with lung cancer in 2021 after doctors also initially overlooked it on a scan he had done previously in 2017. 'I remember a billboard, it was of all people: old, young, black, white, Hispanic, Asian. All it said was: 'This is What HIV looks like.' That's what I want for our community.'
'Anyone with lungs can have lung cancer,' concludes Aurora. 'It's time to remove the blame.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA Pauses Trials of Gilead HIV Combination After Safety Signal
FDA Pauses Trials of Gilead HIV Combination After Safety Signal

Bloomberg

timean hour ago

  • Bloomberg

FDA Pauses Trials of Gilead HIV Combination After Safety Signal

Gilead Sciences Inc. said federal regulators had placed on hold trials of a new experimental once-weekly HIV drug combination therapy after white blood cell counts dropped in some of the patients. The studies were testing two experimental HIV drugs, GS-1720 and GS-4182, when given together. Gilead said the Food and Drug Administration paused the trials due to a ' safety signal ' triggered by a decrease in lymphocyte levels in some patients given the therapy. Lymphocytes are a type of white blood cell that play a critical role in the immune system's ability to fight infections.

LGBTQ+ patients stay up-to-date on preventive care when their doctors are supportive, saving money and lives throughout society
LGBTQ+ patients stay up-to-date on preventive care when their doctors are supportive, saving money and lives throughout society

Yahoo

time2 hours ago

  • Yahoo

LGBTQ+ patients stay up-to-date on preventive care when their doctors are supportive, saving money and lives throughout society

When LGBTQ+ patients are unsure if they can be open about their identity and related health needs, it becomes more difficult for them to access high-quality health care. In our recently published research, my colleagues and I found that how LGBTQ+ people are treated at the doctor's office has a measurable effect on whether they stay up to date with lifesaving preventive care like flu shots, colorectal cancer screenings and HIV testing. We examined how LGBTQ+ adults rated their health care provider across three areas: LGBTQ+ cultural competency, such as if providers used inclusive language on forms and in person; LGBTQ+ clinical competency, such as their doctor's knowledge on all aspects of their health; and experiences of discrimination, such as being told to seek care elsewhere. After analyzing survey data on the experiences of more than 950 LGBTQ+ adults from across the U.S., we saw that three clear patterns emerged. First, 34% of participants reported having positive health care experiences – meaning their providers were culturally and clinically competent about LGBTQ+ health needs, and did not discriminate against them. These patients were more likely to be up to date on at least one preventive service recommended by the U.S. Preventive Services Task Force, compared to those receiving neutral or discriminatory care. Second, 60% of participants reported having neutral experiences, when their providers were clinically competent about LGBTQ+ health needs and didn't discriminate against them, but were not culturally competent. These patients were 43% less likely to get an HIV test compared to patients reporting affirming care. Third, 6% of participants reported experiencing discrimination, when their providers were neither culturally nor clinically competent on LGBTQ+ health. These patients were 24% less likely to get a colorectal cancer screening compared to patients reporting affirming care. Most LGBTQ+ adults in our study reported neutral or even discriminatory care, which leads to avoidable health risks and higher costs for the health system. This provides additional evidence that being supportive of LGBTQ+ patients has measurable improvements for health outcomes. Preventive care saves lives and saves money. When diseases like colorectal cancer or HIV are caught early, treatments are often simpler, more effective and less expensive. When LGBTQ+ patients are made to feel unwelcome or unsafe, we found that they are less likely to get routine preventive care, ultimately driving up long-term costs across the health system. States like North Carolina and Georgia that have more health systems participating in the Human Rights Campaign's Healthcare Equality Index, which evaluates policies and practices around LGBTQ+ care, had higher rates of LGBTQ+ patients reporting positive care experiences compared to states with few participating health systems, such as Tennessee and Alabama. Other researchers have found that health systems participating in the Healthcare Equality Index have lower rates of nurse burnout and better quality of care, along with higher patient satisfaction among all patients. This study was originally funded by the National Institute on Aging, but it was among the first LGBTQ+-focused projects terminated by the Trump administration in its efforts to eliminate 'gender ideology.' Our team has continued the work independently to ensure that the over 1,250 participants who already shared their experiences and data would not have this information sit idly. Our findings reinforce what many LGBTQ+ patients already know – nonjudgmental and competent care is not a luxury, but a public health necessity. This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Nathaniel M. Tran, University of Illinois Chicago Read more: Anti-LGBTQ+ policies harm the health of not only LGBTQ+ people, but all Americans Heteronormativity in health care is harmful for LGBTQ+ patients – and a source of tension for queer and trans doctors Our trans health study was terminated by the government – the effects of abrupt NIH grant cuts ripple across science and society Nathaniel M. Tran received funding from the National Institute on Aging and Vanderbilt University.

Equality Health Launches Mobile Clinic to Expand Access to STD Testing, Treatment, and Prevention in Underserved Communities
Equality Health Launches Mobile Clinic to Expand Access to STD Testing, Treatment, and Prevention in Underserved Communities

Yahoo

time3 hours ago

  • Yahoo

Equality Health Launches Mobile Clinic to Expand Access to STD Testing, Treatment, and Prevention in Underserved Communities

OKLAHOMA CITY, Okla., June 10, 2025 /PRNewswire/ -- Equality Health, an established STD testing and treatment center in Oklahoma City, has announced the launch of its mobile clinic, a great step in improving healthcare access for underserved communities. The mobile clinic will provide HIV and Hepatitis C free rapid testing on site. If a patient is positive for either or both our mobile staff will assist in setting up appointments for them to receive care. The launch of the mobile clinic highlights Equality Health's dedication to bringing essential testing directly to individuals who face challenges in accessing such testing. The mobile clinic is designed to be a compassionate, safe environment in which people from all walks of life can receive the attention they need. For more information about the mobile clinic's services and pop-up locations, please call or text (405) 761-2762. Media Contact Name: Fallon Pate Email: 396419@ Phone: (405) 761-2762 View original content: SOURCE Equality Health Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store